These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2021532)

  • 1. The influence of chronic anaemia on the radiosensitivity of two mouse tumours.
    Koong AC; Hirst DG
    Br J Cancer; 1991 Apr; 63(4):499-502. PubMed ID: 2021532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia.
    Thews O; Koenig R; Kelleher DK; Kutzner J; Vaupel P
    Br J Cancer; 1998 Sep; 78(6):752-6. PubMed ID: 9743294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic anaemia, hyperbaric oxygen and tumour radiosensitivity.
    McCormack M; Nias AH; Smith E
    Br J Radiol; 1990 Oct; 63(754):752-9. PubMed ID: 2242472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of alterations in haematocrit on tumour sensitivity to X-rays.
    Hirst DG; Hazlehurst JL; Brown JM
    Int J Radiat Biol Relat Stud Phys Chem Med; 1984 Oct; 46(4):345-54. PubMed ID: 6334047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude mice.
    Stüben G; Thews O; Pöttgen C; Knühmann K; Vaupel P; Stuschke M
    J Cancer Res Clin Oncol; 2001; 127(6):346-50. PubMed ID: 11414194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of recombinant human erythropoietin treatment on tumour radiosensitivity and cancer-associated anaemia in the mouse.
    Joiner B; Hirst VK; McKeown SR; McAleer JJ; Hirst DG
    Br J Cancer; 1993 Oct; 68(4):720-6. PubMed ID: 8398699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor growth and tumor radiosensitivity in mice given myeloprotective doses of fibroblast growth factors.
    Ding I; Huang K; Snyder ML; Cook J; Zhang L; Wersto N; Okunieff P
    J Natl Cancer Inst; 1996 Oct; 88(19):1399-404. PubMed ID: 8827018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of carbogen and nicotinamide on intravascular oxyhaemoglobin saturations in SCCVII and KHT murine tumours.
    Fenton BM
    Br J Cancer; 1995 May; 71(5):945-9. PubMed ID: 7734318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The response of mouse tumours to fractionated doses of pions: determination of therapeutic gain factor.
    Ogawa Y; Goodman GB; Chaplin DJ; Grulkey W; Lam GK
    Oncology; 1991; 48(1):81-7. PubMed ID: 1987502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adaptive response of mouse tumours to anaemia and retransfusion.
    Hirst DG; Wood PJ
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Apr; 51(4):597-609. PubMed ID: 3495506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the importance of anaemia in radiotherapy? The value of animal studies.
    Hirst DG
    Radiother Oncol; 1991; 20 Suppl 1():29-33. PubMed ID: 2020766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of induced host anaemia on the viability and radiosensitivity of murine malignant cells in vivo.
    Hewitt HB; Blake ER
    Br J Cancer; 1971 Jun; 25(2):323-36. PubMed ID: 5115832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of tumour age response to radiation for cells derived from tissue culture or solid tumours.
    Keng PC; Siemann DW; Wheeler KT
    Br J Cancer; 1984 Oct; 50(4):519-26. PubMed ID: 6487518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
    Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P;
    Eur J Cancer; 2007 Jan; 43(2):258-70. PubMed ID: 17182241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitivity of microscopic tumours of a transplantable mammary adenocarcinoma in mice.
    Haveman J; Jansen W; van der Schueren E; Breur K
    Br J Cancer; 1981 Jun; 43(6):864-70. PubMed ID: 7248162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of misonidazole in combination with radiation dose fractionation.
    Hill RP; Bush RS
    Br J Cancer Suppl; 1978 Jun; 3():255-8. PubMed ID: 277242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.
    Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P
    Eur J Cancer; 2004 Oct; 40(15):2201-16. PubMed ID: 15454245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo studies using BW12C: toxicity, haemoglobin modification and effects on the radiosensitivity of normal marrow and RIF-1 tumours in mice.
    Honess DJ; Nethersell AB; Bleehen NM
    Int J Radiat Biol; 1992 Jan; 61(1):83-94. PubMed ID: 1345934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin restores the anemia-induced reduction in radiosensitivity of experimental human tumors in nude mice.
    Stüben G; Pöttgen C; Knühmann K; Schmidt K; Stuschke M; Thews O; Vaupel P
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1358-62. PubMed ID: 12654448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of hemoglobin level on radiobiological hypoxia in tumors.
    Hirst DG; Brown JM
    Adv Exp Med Biol; 1986; 200():603-8. PubMed ID: 3799352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.